JPS6422A - Prophylactic and remedy for hypocalcemia and bone catabolism - Google Patents

Prophylactic and remedy for hypocalcemia and bone catabolism

Info

Publication number
JPS6422A
JPS6422A JP62085436A JP8543687A JPS6422A JP S6422 A JPS6422 A JP S6422A JP 62085436 A JP62085436 A JP 62085436A JP 8543687 A JP8543687 A JP 8543687A JP S6422 A JPS6422 A JP S6422A
Authority
JP
Japan
Prior art keywords
calcium
preparation
remedy
prophylactic
hypocalcemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62085436A
Other languages
Japanese (ja)
Other versions
JPH0541606B2 (en
JPH0122A (en
Inventor
Shoichi Murata
Yoshinao Nagashima
Kenji Hara
Shigeto Kayane
Takashi Imamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP62-85436A priority Critical patent/JPH0122A/en
Priority claimed from JP62-85436A external-priority patent/JPH0122A/en
Publication of JPS6422A publication Critical patent/JPS6422A/en
Publication of JPH0122A publication Critical patent/JPH0122A/en
Publication of JPH0541606B2 publication Critical patent/JPH0541606B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To obtain a prophylactic preparation or a remedy for diseases caused by insufficiency of calcium in living body tissues, by using calcium hexosephosphate as an active ingredient, thus enabling the drug to be administered for a long period of time without side-actions.
CONSTITUTION: Calcium hexose-phosphate, preferably calcium glucose-phosphate is used, as an active ingredient, to give the subject preparation. The preparation has good absorption properties, increases the calcium concentration in blood and strengthens bone strength. The dose of the preparation is 1W50g, preferably 10W30g/day/adult.
COPYRIGHT: (C)1989,JPO&Japio
JP62-85436A 1987-02-12 1987-04-07 Preventive/therapeutic agents for hypocalcemia and bone metabolic disorders Granted JPH0122A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62-85436A JPH0122A (en) 1987-02-12 1987-04-07 Preventive/therapeutic agents for hypocalcemia and bone metabolic disorders

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62-30513 1987-02-12
JP3051387 1987-02-12
JP62-85436A JPH0122A (en) 1987-02-12 1987-04-07 Preventive/therapeutic agents for hypocalcemia and bone metabolic disorders

Publications (3)

Publication Number Publication Date
JPS6422A true JPS6422A (en) 1989-01-05
JPH0122A JPH0122A (en) 1989-01-05
JPH0541606B2 JPH0541606B2 (en) 1993-06-24

Family

ID=

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1477171A1 (en) 2003-05-16 2004-11-17 Kao Corporation Intestinal mineral absorption capacity improver
JP2005002090A (en) * 2003-05-16 2005-01-06 Kao Corp Alternative agent for vitamin d-like activity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1477171A1 (en) 2003-05-16 2004-11-17 Kao Corporation Intestinal mineral absorption capacity improver
JP2005002091A (en) * 2003-05-16 2005-01-06 Kao Corp Intestinal mineral absorption capacity improver
JP2005002090A (en) * 2003-05-16 2005-01-06 Kao Corp Alternative agent for vitamin d-like activity
JP4634027B2 (en) * 2003-05-16 2011-02-16 花王株式会社 Vitamin D-like active substitute

Also Published As

Publication number Publication date
JPH0541606B2 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
GB2139892B (en) Solid pharmaceutical preparation containing nifedipine
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
DK339289D0 (en) PHARMACEUTICAL PREPARATION
Minot et al. Use of guanidine hydrochloride in treatment of myasthenia gravis
EP0388799A3 (en) Use of human interferon-beta for stimulation of erythropoieses
ATE147623T1 (en) MEDICINAL PREPARATION FOR PRODUCING A STABILIZED POWDER CONTAINING A COMBINATION OF ACETYLSALICYLIC ACID AND METOCLOPRAMIDE AS THE ACTIVE INGREDIENTS
JPS6422A (en) Prophylactic and remedy for hypocalcemia and bone catabolism
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
KR100271087B1 (en) Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
KR900007434A (en) Therapeutics with cystatin as active ingredients
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
Blanchet et al. Effects of methyl methacrylate monomer vapors on respiration and circulation in unanesthetized rats
Laszlo et al. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate
GR3000751T3 (en) Tpa-containing medical composition and use thereof
KR880002521A (en) Pharmaceutical formulation
ATE66375T1 (en) USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.
JPS643123A (en) Remedy for skin inflammation
RU92001958A (en) METHOD OF OBTAINING FIBRINE PASTE
JPS5735511A (en) Dermatic medicine for external application
JPS6442423A (en) Remedy containing propaphenone antipode
JPS6463521A (en) Trapidyl-containing drug composition, manufacture and related therapeutical use
HK63592A (en) Medical preparation comprising aspoxicillin,a method for its preparation,and the use of such a preparation for the manufacture of a medicament
RU2119342C1 (en) Herbs species n 2 with common restorative effect
NO952426L (en) New drug containing 3,7-diazabicyclo [3.3.1] Nonan compounds
Kustos et al. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. II. Effects of the type and localisation of fracture on the urinary excretion of hydroxyproline and glycosaminoglycans

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070624

Year of fee payment: 14